Startseite › Brustkrebs › Connecticut › New Haven
Klinische Studien zu Brustkrebs in New Haven, CT
37 Studien zu Brustkrebs suchen Teilnehmer an Standorten in und um New Haven (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 2
- Yale Cancer Center, New Haven
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Teilnehmer gesuchtPhase 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Teilnehmer gesuchtPhase 1/2
- Yale University School of Medicine, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Yale University - Yale University School of Medicine, New Haven
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Teilnehmer gesuchtPhase 1
- Yale Cancer Center, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Yale Cancer Center, New Haven
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Teilnehmer gesuchtPhase 3
- Yale Cancer Center ( Site 0060), New Haven
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Teilnehmer gesuchtPhase 3
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale University/Yale Cancer Center/Yale School of Medicine, New Haven
- Smilow Cancer Hospital Care Center - North Haven, North Haven · 7 mi entfernt
- und 2 weitere
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Teilnehmer gesuchtPhase 3
- Research Site, New Haven
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Clinical Trial Site, New Haven
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Teilnehmer gesucht
- Yale Cancer Center, New Haven
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
Teilnehmer gesuchtPhase 1
- Yale University School Of Medicine, New Haven
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Teilnehmer gesuchtPhase 2
- Yale Cancer Center Clinical Trials Office, New Haven
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Teilnehmer gesuchtPhase 3
- Yale New Haven Hospital- Yale Cancer Center, New Haven
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Teilnehmer gesuchtPhase 1/2
- Yale Cancer Center, New Haven
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Teilnehmer gesuchtPhase 3
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Teilnehmer gesuchtPhase 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi entfernt
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi entfernt
- und 1 weitere
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Teilnehmer gesuchtPhase 3
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Yale Cancer Center, New Haven
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Teilnehmer gesuchtPhase 2
- Yale University Cancer Center, New Haven
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Teilnehmer gesucht
- Yale Cancer Center, New Haven
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Teilnehmer gesuchtPhase 2
- Yale Cancer Center at Yale University School of Medicine, New Haven
- Smilow Cancer Hospital Care center at North Haven, North Haven · 7 mi entfernt
- Smilow Cancer Hospital Care center at Derby, Derby · 8 mi entfernt
- und 1 weitere
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Teilnehmer gesuchtPhase 3
- Yale Cancer Center - Smilow Cancer Hospital, New Haven
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Teilnehmer gesuchtPhase 3
- Yale University, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Yale University, Yale Cancer Center, New Haven
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Teilnehmer gesuchtPhase 1
- Yale Cancer Center Smilow Cancer Hospital, New Haven
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
Teilnehmer gesuchtBeobachtungsstudie
- Yale Cancer Center, New Haven
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Teilnehmer gesuchtPhase 3
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Smilow Cancer Hospital - North Haven, North Haven · 7 mi entfernt
- Smilow Cancer Hospital - Derby, Derby · 8 mi entfernt
- und 1 weitere
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Teilnehmer gesuchtPhase 2
- Yale Cancer Center, New Haven
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Teilnehmer gesuchtPhase 3
- Yale-New Haven Hospital Saint Raphael Campus, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5 mi entfernt
- und 4 weitere
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Yale University, Yale Cancer Center, New Haven
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Teilnehmer gesucht
- Yale University, New Haven
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
Teilnehmer gesuchtPhase 2
- Yale University, New Haven
The Cancer of the Pancreas Screening-5 CAPS5)Study
Teilnehmer gesuchtPhase 3
- Yale University, New Haven
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Teilnehmer gesuchtPhase 1
- Yale University, New Haven
Brustkrebs-Studien in anderen Städten
- New York City, NY134 Studien
- Houston, TX126 Studien
- Boston, MA111 Studien
- Nashville, TN80 Studien
- Los Angeles, CA72 Studien
- Edison, NJ68 Studien
- St. Louis, MO64 Studien
- Durham, NC63 Studien
- Queens, NY63 Studien
- Chicago, IL58 Studien
- Philadelphia, PA56 Studien
- Dallas, TX55 Studien
Weitere Studien in New Haven
- Nichtkleinzelliges Lungenkarzinom41 Studien
- Krebs (alle Arten)33 Studien
- Metastasierender Krebs23 Studien
- Lungenkrebs22 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich22 Studien
- Eierstockkrebs21 Studien
- Kolorektales Karzinom20 Studien
- Prostatakrebs20 Studien
- Opioïdüberdosierung18 Studien
- Alkoholgebrauchsstörung (AUD)17 Studien
- Akute myeloische Leukämie17 Studien
- Bauchspeicheldrüsenkrebs16 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.